HIV Specialist ViiV Healthcare is 100% dedicated to preventing, treating and curing HIV, presenting a focused opportunity for specialized product collaborations, lifecycle management programs, and patient support services aligned with HIV care ecosystems.

Clinical Data Recent and upcoming Phase IIIb/data presentations at major HIV conferences indicate active pipeline advancement and opportunities to align medical affairs, KOL engagement, and payer discussions around two-drug regimens like Dovato in comparison to competitors.

Strategic Partnerships Active collaborations with health systems and NGOs (for example CIDRZ and CBCHS) reveal a channel for co-funded programs, access initiatives, and community-based outreach that can be expanded for Rare/underrepresented populations and SRHR integration.

Commercial Readiness Significant funding and sizable revenue potential position ViiV for strategic partnerships in manufacturing, distribution, and digital engagement platforms, enabling joint market access, patient adherence programs, and real-world evidence gathering.

Tech & Engagement Utilization of diverse tech stack and digital tracking (Optimizely, Facebook Pixel, 23andMe, etc.) suggests opportunities for data-driven patient engagement, precision marketing, and behavioral insights to optimize trials, advocacy campaigns, and treatment adherence initiatives.